The value of Ki-67 as a prognostic biomarker in osteosarcoma: A systematic review and meta-analysis

Asian J Surg. 2022 Dec;45(12):2978-2980. doi: 10.1016/j.asjsur.2022.06.130. Epub 2022 Jul 7.

Authors

Yanqiang Chen¹, Jingsheng Liu², Bin Zhou², Mingxuan Yang², Haijun Feng²

Affiliations

¹ Department of Orthopedic, Lanzhou University Second Hospital, Lanzhou, 730000, China. Electronic address: [email protected].
² Department of Orthopedic, Lanzhou University Second Hospital, Lanzhou, 730000, China.

PMID: 35811212
DOI: 10.1016/j.asjsur.2022.06.130

No abstract available

Keywords: Ki-67; Meta-analysis; Osteosarcoma; Prognosis.

Publication types

Meta-Analysis
Systematic Review
Letter

MeSH terms

Biomarkers, Tumor
Bone Neoplasms* / diagnosis
Humans
Ki-67 Antigen
Osteosarcoma* / diagnosis
Prognosis

Substances

Ki-67 Antigen
Biomarkers, Tumor